Publication Name	World Journal of Gastroenterology
Manuscript ID	79998
Country	India

Received	2022-09-13 16:45
Peer-Review Started	2022-09-13 16:46
To Make the First Decision
Return for Revision	2022-09-29 20:38
Revised	2022-10-13 15:40
Second Decision	2022-11-21 03:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-11-21 22:13
Articles in Press	2022-11-21 22:13
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-01-11 21:49
Typeset the Manuscript	2023-01-12 08:39
Publish the Manuscript Online	2023-01-20 13:48

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	COVID-19 and liver: Are footprints still there?
Manuscript Source	Invited Manuscript
All Author List	Tarana Gupta and Hemant Sharma
ORCID	Author(s) ORCID Number Tarana Gupta http://orcid.org/0000-0003-3453-2040 Hemant Sharma http://orcid.org/0000-0001-8813-8933
Funding Agency and Grant Number
Corresponding Author	Tarana Gupta, Doctor, MBBS, MD, Professor, Department of Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Medical Mor, Rohtak 124001, Haryana, India. taranagupta@gmail.com
Key Words	COVID-19; Chronic liver disease; Cirrhosis; Liver injury; Transaminases; Non-alcoholic fatty liver disease; Post-acute COVID-19 syndrome
Core Tip	Coronavirus disease 2019 (COVID-19) and liver involvement had been a major concern since beginning of COVID-19 pandemic. Deranged liver functions with raised transaminases were reported in patients with severe COVID-19 disease. On the other hand, acute hepatitis or liver failure was uncommon. Severe acute respiratory syndrome coronavirus 2 virus associated cytokine surge, systemic inflammation, direct viral infection, drugs like remedisivir, steroids, lopinavir-ritonavir were main causative factor for raised transaminases. Patients with pre-existing chronic liver diseases especially non-alcoholic fatty liver disease were found to be risk factor for causing increased mortality in patients with severe COVID-19 disease.
Publish Date	2023-01-20 13:48
Citation	Gupta T, Sharma H. COVID-19 and liver: Are footprints still there? World J Gastroenterol 2023; 29(4): 656-669
URL	https://www.wjgnet.com/1007-9327/full/v29/i4/656.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i4.656

Full Article (PDF)	WJG-29-656.pdf
Full Article (Word)	WJG-29-656.docx
Manuscript File	79998_Auto_Edited-LM-Language editing-Webster J-Clear.docx
Answering Reviewers	79998-Answering reviewers.pdf
Audio Core Tip	79998-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	79998-Conflict-of-interest statement.pdf
Copyright License Agreement	79998-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79998-Language certificate.pdf
Peer-review Report	79998-Peer-review(s).pdf
Scientific Misconduct Check	79998-Bing-Chen YL-2.png
Scientific Editor Work List	79998-Scientific editor work list.pdf